CD8A and melanoma: Here, we review the known endothelial adhesion molecules and chemotactic factors involved in differential recruitment of CD8+ T-cells, monocytes and neutrophils into melanoma tumours, and present clinical evidence that these molecules and factors are crucial in affecting immunotherapy response and outcome of melanoma patients.